Results 221 to 230 of about 45,138 (251)

Emerging drugs for treatment of focal segmental glomerulosclerosis

Expert Opinion on Emerging Drugs, 2020
Howard Trachtman
exaly  

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

Nature Medicine, 2011
Vasil Peev, Vineet Gupta, Franz Schaefer
exaly  

Activation of the TGF- β/Smad signaling pathway in focal segmental glomerulosclerosis

Kidney International, 2003
Kyung Chul Moon, Hyun Soon Lee, Hye Kyoung Hong   +2 more
exaly  

C1q nephropathy: A variant of focal segmental glomerulosclerosis

Kidney International, 2003
Samih Nasr, Glen S Markowitz, M Barry Stokes   +2 more
exaly  

Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion

Kidney International, 2000
Kevin J McCarthy, Kathleen E Walsh, T C Welbourne   +2 more
exaly  

CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome

Kidney International, 2004
Volker Vielhauer, Stephan Segerer, Hans-Joachim Anders   +2 more
exaly  

INSULIN-INDUCED GLOMERULOSCLEROSIS IN THE RABBIT

Journal of Experimental Medicine, 1963
Gordon R Hennigar
exaly  

The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis1

Kidney International, 2005
Jeroen van der Laak, Jack F M Wetzels, Bart Smeets   +2 more
exaly  

Glomerulosclerosis predicts poor renal outcome in patients with idiopathic membranous nephropathy

International Urology and Nephrology, 2020
Haofei Hu, haiying SONG, Xiaohua Xiao
exaly  

Testosterone and 17β-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice

Kidney International, 2011
Paola Catanuto, Sophie Doublier, Xiaomei Xia   +2 more
exaly